Suzanne Kirby is an Oncology physician affiliated with University of North Carolina at Chapel Hill. OpenAlex indexes 37 publications with 5,102 citations (h-index 17).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
300 Ashville Ave
Suite 310
Cary, NC 275188682
Telephone
919-233-8585Registry record last updated 7 Jan 2009.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- SERVIER PHARMACEUTICALS LLCProgram year20251 payment
- AstraZeneca Pharmaceuticals LPProgram year20251 payment
- Celgene CorporationProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
66.2%Kinase inhibitor29.9%Brukinsa49%Jakafi24%Imatinib Mesylate11%Tasigna7%Imbruvica6%Jaypirca3%Part D<11 patientsThalidomide Analog25.6%Lenalidomide44%Revlimid42%Pomalyst14%Part D≥35 patients+ 5 more classes in this area
Dermatology
9%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor9%Acyclovir100%Part D≥36 patientsMetabolism & gastrointestinal
7.9%Proton pump inhibitor3.2%Pantoprazole Sodium100%Part D≥18 patientsSerotonin-3 Receptor Antagonist2%Ondansetron Hcl100%Part D≥16 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2004–2007 per NIH RePORTER. The latest:
- Chemokines in Radiation Induced Pulmonary Fibrosis
Univ of North Carolina Chapel Hill
FY2007$227,033R01CA098641 - Chemokines in Radiation Induced Pulmonary Fibrosis
Univ of North Carolina Chapel Hill
FY2006$233,813R01CA098641 - Chemokines in Radiation Induced Pulmonary Fibrosis
University of North Carolina Chapel Hill
FY2005$239,440R01CA098641
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Lisa Carey, MD
University of North Carolina at Chapel Hill
Diana Perkins, MD
University of North Carolina at Chapel Hill
Norman Sharpless, MD
University of North Carolina at Chapel Hill
Douglas Drossman, MD
University of North Carolina at Chapel Hill
Carl June, MD
University of Pennsylvania
Christopher Benz, MD
Buck Institute for Research on Aging
Christina Fitzmaurice, MD
Gundersen Health System
Beth Karlan, MD
Cedars-Sinai Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”